Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FYM54
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,966
Award facts
- Contract value 100% obligated
- $32,966.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). The delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform at its facility in Park Ridge, Illinois, and no subcontractors are identified for this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare facilities worldwide. The underlying PPV-G GEN V contract, designated SPE2DR and awarded on November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, positioning the company as a critical supplier within the Department of Defense's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FYM54?
SPE2DB26FYM54 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FYM54 worth?
The government has obligated $32,966 on SPE2DB26FYM54.
Is contract SPE2DB26FYM54 an order under another contract?
Yes. SPE2DB26FYM54 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM54 competed?
The extent of competition for SPE2DB26FYM54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award